Showing results (121-130 of 486) with videos related to

Sort By:
Pageof 49
Frontiers in Oncology|December 27, 2021
Case Report: Graft Versus Tumor Effect After Non-Myeloablative Allogeneic Stem-Cell Transplantation in a Patient With Brentuximab-Vedotin Refractory Sezary SyndromeGeorg-Nikolaus Franke, Konstantin Dumann, Madlen Jentzsch, et al.
Ejhaem|August 21, 2023
Next-generation sequencing of baseline genetic mutations and outcomes of eltrombopag and azacitidine therapy in patients with myelodysplastic syndromes and thrombocytopenia: Data from the SUPPORT clinical trialPedro Marques Ramos, Jeea Choi, Catarina D Campbell, et al.
Leukemia|May 18, 2021
Luspatercept restores SDF-1-mediated hematopoietic support by MDS-derived mesenchymal stromal cellsManja Wobus, Anna Mies, Nandini Asokan, et al.
Biology of Blood and Marrow Transplantation : Journal of the American Society for Blood and Marrow Transplantation|December 5, 2012
Reconstitution of interleukin-17-producing T helper cells after allogeneic hematopoietic cell transplantationFelix Bahr, Rebekka Wehner, Uwe Platzbecker, et al.
International Journal of Molecular Sciences|February 25, 2023
Clonal Hematopoiesis Mutations Are Present in Atherosclerotic Lesions in Peripheral Artery DiseasePetra Büttner, Julia Böttner, Knut Krohn, et al.
Frontiers in Oncology|March 18, 2020
Allogeneic Hematopoietic Stem Cell Transplantation in a Rare Case of Tonsillar Mast Cell SarcomaAnne Sophie Kubasch, Georg-Nikolaus Franke, Ali Aldaoud, et al.
American Journal of Hematology|July 21, 2021
Clinical implications of SRSF2 mutations in AML patients undergoing allogeneic stem cell transplantationJuliane Grimm, Madlen Jentzsch, Marius Bill, et al.
NPJ Digital Medicine|April 30, 2025
Predicting progression events in multiple myeloma from routine blood workMaximilian Ferle, Nora Grieb, Markus Kreuz, et al.
Npj Biomedical Innovations|June 2, 2026
Development and early feasibility testing of machine-learning algorithms to non-invasively assess hemoglobin levelsSimon Hefner, Philipp Stoffers, Benedikt Langenberger, et al.
Blood|February 3, 2009
Lenalidomide, adriamycin, and dexamethasone (RAD) in patients with relapsed and refractory multiple myeloma: a report from the German Myeloma Study Group DSMM (Deutsche Studiengruppe Multiples Myelom)Stefan Knop, Christian Gerecke, Peter Liebisch, et al.
Pageof 49